Why the study?
Does a first myocardial infarction lead to increased plasma levels of hs-CRP and hemostatic factors compared to matched referents?
Does a first myocardial infarction lead to increased plasma levels of hs-CRP and hemostatic factors compared to matched referents?
A first myocardial infarction does not appear to induce long-term increases in hs-CRP or hemostatic factors compared to matched controls.
Answers are grounded in this paper and cite their sources.
Post-MI hs-CRP and hemostatic trajectories mirror matched controls; leaves open their incremental value for long-term risk stratification.
The objective of this study was to determine whether a first myocardial infarction leads to increased plasma levels of hemostatic factors and high sensitive C-reactive protein (hs-CRP) and whether the association between theses biomarkers and myocardial infarction was greater at follow-up compared with baseline. Of more than 36,000 persons screened in northern Sweden, 78 developed a first myocardial infarction (on average 18 months after sampling) in a population-based, prospective, nested patient-referent study. Fifty of these had participated in a follow-up health survey (on average 8 and a half years between surveys) and were sex-matched and age-matched with 56 referents. The mean increases in hs-CRP, tissue plasminogen activator (tPA) mass, plasminogen activator inhibitor-1 mass, and tPA/plasminogen activator inhibitor-1 complex concentration and von Willebrand factor among patients and referents were comparable during follow-up. Conditional logistic regression indicated that hs-CRP was not significantly associated with first myocardial infarction in a univariate analysis, whereas high plasma levels of tPA and creatinine were significantly associated with outcome at baseline and follow-up. tPA/plasminogen activator inhibitor-1 complex was not superior to tPA as a risk marker in this study. A first myocardial infarction did not in this study induce significantly different changes in plasma levels of hs-CRP and hemostatic factors among patients compared with referents during follow-up.
No takes yet. Share an insight, caveat, or question.
Thøgersen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: